Phase I/II Intra-patient Dose Escalation Study of Vorinostat in Children With Relapsed Solid Tumor, Lymphoma or Leukemia.
Active, no longer recruiting
Phase of Trial: Phase I/II
Latest Information Update: 20 Oct 2016
At a glance
- Drugs Vorinostat (Primary)
- Indications Leukaemia; Lymphoma; Solid tumours
- Focus Adverse reactions
- 14 Oct 2016 Planned End Date changed from 1 Dec 2017 to 1 Feb 2018.
- 14 Oct 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Nov 2017.
- 14 Oct 2016 Status changed from recruiting to active, no longer recruiting.